AVROBIO Analysis
| AVRODelisted Stock | USD 1.40 0.04 2.78% |
AVROBIO is overvalued with Real Value of 1.17 and Hype Value of 1.4. The main objective of AVROBIO delisted stock analysis is to determine its intrinsic value, which is an estimate of what AVROBIO is worth, separate from its market price. There are two main types of AVROBIO's stock analysis: fundamental analysis and technical analysis.
The AVROBIO stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. AVROBIO is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. AVROBIO Stock trading window is adjusted to America/New York timezone.
AVROBIO |
AVROBIO Stock Analysis Notes
About 69.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.6. Some equities with similar Price to Book (P/B) outperform the market in the long run. AVROBIO had not issued any dividends in recent years. The entity had 1:12 split on the 21st of June 2024. AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Avrobio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people. For more info on AVROBIO please contact the company at 617 914 8420 or go to https://www.avrobio.com.AVROBIO Investment Alerts
| AVROBIO is now traded under the symbol TECX. Please update your portfolios or report it if you believe this is an error. Report It! | |
| AVROBIO is not yet fully synchronised with the market data | |
| AVROBIO may become a speculative penny stock | |
| AVROBIO has a very high chance of going through financial distress in the upcoming years | |
| AVROBIO currently holds about 132.41 M in cash with (63.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 69.0% of the company shares are held by institutions such as insurance companies |
AVROBIO Upcoming and Recent Events
Earnings reports are used by AVROBIO to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
AVROBIO Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 63.75 M.AVROBIO Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific AVROBIO insiders, such as employees or executives, is commonly permitted as long as it does not rely on AVROBIO's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases AVROBIO insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Leonard Braden Michael over six months ago Acquisition by Leonard Braden Michael of 296882 shares of AVROBIO at 1.3 subject to Rule 16b-3 | ||
Steven Avruch over six months ago Acquisition by Steven Avruch of 32834 shares of AVROBIO subject to Rule 16b-3 | ||
Erik Ostrowski over six months ago Exercise or conversion by Erik Ostrowski of 40084 shares of AVROBIO subject to Rule 16b-3 | ||
Erik Ostrowski over a year ago Acquisition by Erik Ostrowski of 70000 shares of AVROBIO subject to Rule 16b-3 | ||
Christopher Paige over a year ago Acquisition by Christopher Paige of 17643 shares of AVROBIO subject to Rule 16b-3 | ||
Geoff MacKay over a year ago Exercise or conversion by Geoff MacKay of 45999 shares of AVROBIO subject to Rule 16b-3 | ||
Geoff MacKay over a year ago Acquisition by Geoff MacKay of 300667 shares of AVROBIO subject to Rule 16b-3 |
AVROBIO Outstanding Bonds
AVROBIO issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. AVROBIO uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most AVROBIO bonds can be classified according to their maturity, which is the date when AVROBIO has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| AXA EQUITABLE HLDGS Corp BondUS054561AJ49 | View | |
| AXA EQUITABLE HLDGS Corp BondUS054561AM77 | View | |
| AXASA 6379 Corp BondUS054536AC14 | View | |
| AXA SA 86 Corp BondUS054536AA57 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View |
AVROBIO Predictive Daily Indicators
AVROBIO intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of AVROBIO stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About AVROBIO Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how AVROBIO prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling AVROBIO shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as AVROBIO. By using and applying AVROBIO Stock analysis, traders can create a robust methodology for identifying AVROBIO entry and exit points for their positions.
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Avrobio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding AVROBIO to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in AVROBIO Stock
If you are still planning to invest in AVROBIO check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AVROBIO's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |